NEWCaplight raises a $16M Series A, led by BlackRock and Fin Capital →
Skip to main content
Caplight Logo









InvAscent

InvAscent

Hyderabad, Telanganainvascent.com

Overview

InvAscent is India's leading life sciences private equity firm managing an AUM of over USD 800 million with investments in over 35 companies across pharma, healthcare delivery, medical devices, animal health, nutraceuticals, and healthtech industries . The firm focuses on small and mid-sized businesses in the Indian pharmaceutical, healthcare, animal health, and medical technology industries .

Year Founded

2005

AUM

$800M

Portfolio Companies

12

Investments

InvAscent investments
CompanyDateStageLead
Apex HospitalsSep 2025Private EquityLead
Geri CareJan 2025Series ALead
Maiva PharmaMay 2024Private EquityLead
ABI Health TechnologiesDec 2023Private EquityLead
Accumax Lab DevicesMay 2022Series CCo-investor

Sector & Stage Mix

Industry, funding stage, and valuation band breakdowns.

Premium
SeedSeries ASeries BGrowth

Unlock portfolio analytics

Sign up to view full sector, stage, and valuation breakdowns for this investor.

Investment Activity

Yearly cadence, pace, and funding raised over time.

Premium
2021
2022
2023
2024
2025
2026

Unlock portfolio analytics

Sign up to explore yearly investment trends and funding raised over time.

FAQ

Firmographic Details

HeadquartersHyderabad, Telangana
Year Founded2005
AUM$800M

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.